CA3175640A1 - Scd83 for wound healing, hair growth, and skin and hair care - Google Patents
Scd83 for wound healing, hair growth, and skin and hair careInfo
- Publication number
- CA3175640A1 CA3175640A1 CA3175640A CA3175640A CA3175640A1 CA 3175640 A1 CA3175640 A1 CA 3175640A1 CA 3175640 A CA3175640 A CA 3175640A CA 3175640 A CA3175640 A CA 3175640A CA 3175640 A1 CA3175640 A1 CA 3175640A1
- Authority
- CA
- Canada
- Prior art keywords
- scd83
- protein
- amino acids
- composition
- wounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A61K38/1774—Immunoglobulin superfamily (e.g. CD2, CD4, CD8, ICAM molecules, B7 molecules, Fc-receptors, MHC-molecules)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Birds (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20169899.0A EP3895723A1 (en) | 2020-04-16 | 2020-04-16 | Scd83 for wound healing, hair growth, and skin and hair care |
| EP20169899.0 | 2020-04-16 | ||
| PCT/EP2021/059923 WO2021209607A1 (en) | 2020-04-16 | 2021-04-16 | Scd83 for wound healing, hair growth, and skin and hair care |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3175640A1 true CA3175640A1 (en) | 2021-10-21 |
Family
ID=70294945
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3175640A Pending CA3175640A1 (en) | 2020-04-16 | 2021-04-16 | Scd83 for wound healing, hair growth, and skin and hair care |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230270820A1 (https=) |
| EP (3) | EP3895723A1 (https=) |
| JP (1) | JP2023522022A (https=) |
| CA (1) | CA3175640A1 (https=) |
| ES (1) | ES3028665T3 (https=) |
| HR (1) | HRP20250640T1 (https=) |
| HU (1) | HUE072389T2 (https=) |
| PL (1) | PL4135745T3 (https=) |
| RS (1) | RS66881B1 (https=) |
| SM (1) | SMT202500330T1 (https=) |
| WO (1) | WO2021209607A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102024110866A1 (de) | 2024-04-18 | 2025-10-23 | Christian Arnold | Pharmazeutische Zusammensetzung zur Heilung einer Wunde |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1422241A1 (en) | 2002-11-19 | 2004-05-26 | Alexander Steinkasserer | Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseases |
| CA2725198A1 (en) * | 2008-05-23 | 2009-11-26 | Argos Therapeutics, Inc. | Novel soluble cd83 polypeptides, formulations and methods of use |
| JP2013040160A (ja) * | 2011-07-01 | 2013-02-28 | Genentech Inc | 自己免疫疾患を治療するための抗cd83アゴニスト抗体の使用 |
-
2020
- 2020-04-16 EP EP20169899.0A patent/EP3895723A1/en not_active Withdrawn
-
2021
- 2021-04-16 CA CA3175640A patent/CA3175640A1/en active Pending
- 2021-04-16 SM SM20250330T patent/SMT202500330T1/it unknown
- 2021-04-16 WO PCT/EP2021/059923 patent/WO2021209607A1/en not_active Ceased
- 2021-04-16 HU HUE21717933A patent/HUE072389T2/hu unknown
- 2021-04-16 HR HRP20250640TT patent/HRP20250640T1/hr unknown
- 2021-04-16 JP JP2022562631A patent/JP2023522022A/ja active Pending
- 2021-04-16 US US17/996,366 patent/US20230270820A1/en active Pending
- 2021-04-16 PL PL21717933.2T patent/PL4135745T3/pl unknown
- 2021-04-16 ES ES21717933T patent/ES3028665T3/es active Active
- 2021-04-16 EP EP21717933.2A patent/EP4135745B1/en active Active
- 2021-04-16 EP EP25168764.6A patent/EP4591944A3/en active Pending
- 2021-04-16 RS RS20250521A patent/RS66881B1/sr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP4135745C0 (en) | 2025-05-07 |
| JP2023522022A (ja) | 2023-05-26 |
| EP4591944A3 (en) | 2025-10-01 |
| PL4135745T3 (pl) | 2025-09-15 |
| ES3028665T3 (en) | 2025-06-19 |
| EP4135745B1 (en) | 2025-05-07 |
| SMT202500330T1 (it) | 2025-11-10 |
| EP3895723A1 (en) | 2021-10-20 |
| HRP20250640T1 (hr) | 2025-09-12 |
| WO2021209607A1 (en) | 2021-10-21 |
| EP4135745A1 (en) | 2023-02-22 |
| US20230270820A1 (en) | 2023-08-31 |
| RS66881B1 (sr) | 2025-07-31 |
| HUE072389T2 (hu) | 2025-11-28 |
| EP4591944A2 (en) | 2025-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI648401B (zh) | 生長分化因子15(gdf-15)構築體 | |
| JP2001515360A (ja) | ▲II▼型TGF−βレセプター/免疫グロブリン定常領域融合タンパク質 | |
| JPH09509825A (ja) | 骨細胞を刺激するための方法および組成物 | |
| ES2398039T3 (es) | Uso de anticuerpos antagonistas anti-TGF-beta para tratar o prevenir la pérdida de función renal | |
| EP3038635A2 (en) | Systems, compositions, and methods for transplantation and treating conditions | |
| MX2007009235A (es) | Composiciones y metodos para tratar desordenes fibroticos. | |
| US9351914B2 (en) | Methods for modulating hair growth using truncated laminin-511 | |
| CN108129574A (zh) | 包括白细胞介素10和白细胞介素4的融合蛋白 | |
| EP4135745B1 (en) | Scd83 for wound healing, hair growth, and skin and hair care | |
| US12006343B2 (en) | C4BP-based compounds for treating immunological diseases | |
| US20140288010A1 (en) | Compositions and Methods for Increasing Stem Cell Survival | |
| CZ305653B6 (cs) | Farmaceutický prostředek | |
| HK40129498A (en) | Scd83 for wound healing, hair growth, and skin and hair care | |
| IL147123A (en) | Use of compositions containing at least one soluble form of G – HLA for the preparation of a medicinal product for the treatment of inflammatory pathologies of the skin | |
| KR20010033640A (ko) | 신규 폴리펩티드, 그 폴리펩티드를 암호하는 cDNA 및그 용도 | |
| AU2001247825B2 (en) | Angiogenic onchocerca volvulus proteins and uses thereof | |
| US11524091B2 (en) | GILZ formulations for wound healing | |
| HUP0401323A2 (hu) | IL-18 inhibitorok alkalmazása túlérzékenységi rendellenességek esetén | |
| CN112402454A (zh) | 预激活间充质干细胞在治疗皮肤创伤的免疫生物学方面的应用 | |
| KR20010030984A (ko) | 폴리펩티드, 그 폴리펩티드를 암호화하는 cDNA 및이들의 용도 | |
| Class et al. | Patent application title: Methods for Modulating Hair Growth Using Truncated Laminin-511 Inventors: M. Peter Marinkovich (Redwood City, CA, US) Jing Gao (Mountain View, CA, US) Xiaoyu Xu (Foster City, CA, US) Jayakumar Rajadas (Cupertino, CA, US) Jayakumar Rajadas (Cupertino, CA, US) | |
| Wang | Molecular and cell biology of pig skin: a model for wound healing | |
| Cruz | Altered gene expression of IL-1 Alpha, IL-1 Beta, and KGF-1 in early cutaneous wounds of restrained Mice |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 4TH ANNIV.) - STANDARD Year of fee payment: 4 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250409 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250409 |
|
| D11 | Substantive examination requested |
Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D11-D117 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION RECEIVED Effective date: 20250415 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P11-P101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - VOLUNTARY AMENDMENT Effective date: 20250415 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20250415 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20250416 |
|
| D00 | Search and/or examination requested or commenced |
Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D00-D118 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION REQUIREMENTS DETERMINED COMPLIANT Effective date: 20250602 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT Effective date: 20250602 |
|
| P13 | Application amended |
Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED Effective date: 20250602 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20250602 |
|
| D11 | Substantive examination requested |
Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D11-D155 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: ALL REQUIREMENTS FOR EXAMINATION DETERMINED COMPLIANT Effective date: 20250605 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 5TH ANNIV.) - STANDARD Year of fee payment: 5 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20260407 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20260407 |